pharma-company /Medicinal products /Active ingredients

Rx · PZN 19279542, 19477532, 19680322, 19785593…

WEZENLA 90 mg solution for injection in a pre-filled syringe

German trade nameWEZENLA 90 mg Injektionslösung in einer Fertigspritze

Active ingredientUstekinumabPharmaceutical formSolution for injection/infusion

Consistently available

9.6

out of 10

0510

Pharma availability index · 30 days · as of 01.08.2026


Storage temperature and transport temperature

Cold chain 2–8 °C

Average purchase price (B2B)

~ €2,213

We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.

WEZENLA 90 mg solution for injection in a pre-filled syringe is consistently available through wholesale. We are happy to review your purchase price and advise you on it.

Review purchasing terms

WEZENLA 90 mg solution for injection in a pre-filled syringe contains the active ingredient Ustekinumab and comes as Solution for injection/infusion. 10 pack sizes of this product are recorded. Availability in German wholesale varied over the past 30 days depending on pack size: from index 0.0 to 9.6 out of 10. The best-available pack was consistently available.


Pack sizes · 10 PZN

PZNIndex 7 dIndex 30 d Highest known purchase price
192795429.39.6~ €2,351
198459295.15.5~ €2,326
197855935.15.3~ €2,235
197800935.15.1~ €2,235
194775324.04.2~ €1,785
198735704.04.2~ €2,231
200010362.52.5~ €2,350
196242751.31.8~ €2,278
196803220.00.0~ €2,111
201751730.00.0~ €2,232

We are happy to advise you on sources of supply, purchase prices and procurement optimisation for your pharmaceutical wholesale business or your pharmacy.

Get in touch

The pharma availability index is averaged from the data available to us. Purchase prices are rounded approximations in euros. The average purchase price was calculated across all 10 recorded PZNs.